Muller et al. also reported a two-fold increase in tacrolimus dose requirement for carriers of CYP3A5*1/*1 and CYP3A5*1/*3 compared with those who harbor CYP3A5*3/*3 in South African kidney transplant recipients [35]. Here, CYP3A5 is linked to medical procedure.